Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol

Annals of Pharmacotherapy

Volumn 44, Issue 7-8, 2010, Pages 1342-1344

  O'Mara, Keliana ^a   Gal, Peter ^a,b,c   DaVanzo, Christie ^a  

^a The Women's Hospital of Greensboro   (United States)

^b Graduate Pharmacy Education   (United States)

^c University of North Carolina   (United States)

Author keywords

Clonidine; Neonate; Tramadol withdrawal

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CHLORAL HYDRATE; CLONIDINE; DIAZEPAM; LORAZEPAM; METHADONE; MORPHINE; PHENOBARBITAL; TRAMADOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CASE REPORT; CHLAMYDIASIS; CLINICAL FEATURE; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INFANT; MAINTENANCE THERAPY; MALE; MATERNAL TREATMENT; NEWBORN; NEWBORN DISEASE; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SEIZURE; SHOULDER INJURY; SHOULDER PAIN; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; COMPLICATION; DOSE RESPONSE; NEONATAL ABSTINENCE SYNDROME; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATIONS; TIME;

ADRENERGIC ALPHA-AGONISTS; ADULT; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; TIME FACTORS; TRAMADOL;

EID: 77954588358     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M758     Document Type: Article

References (10)

1. Package insert. Tramadol tablets (Ultram). Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., February 2007.
2. Claashsen-van der Grinten HL, Verbruggen I, van der Berg P, Sporken J, Kollee L. Different pharmacokinetics of tramadol in mothers treated for labour pain and in their neonates. Eur J Clin Pharmacol 2005;61:523-9. DOI 10.1007/s00228-005-0955-0
3. Anderson G. Pregnancy-induced changes in pharmacokinetics. Clin Pharmacokinet 2005;44:989-1008. DOI 10.2165/00003088-200544100-00001
4. Senay E, Adams E, Geller A, et al. Physical dependence on Ulram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms. Drug Alcohol Depend 2003;69:233-41. DOI 10.1016/S0376-8716(02)00321-6
5. Lipsitz P. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr (Phila) 1975;14:592-4.
6. Willaschek C, Wolter E, Buchhorn R. Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother. Eur J Clin Pharmacol 2009;65:429-30. DOI 10.1007/s00228-008-0598-z
7. Meyer F, Rimasch H, Blaha B, Banditt P. Tramadol withdrawal in a neonate. Eur J Clin Pharmacol 1997;53:159-60.
8. Esmaeili A, Keinhorst A, Schuster T, Beske F, Schlosser R, Bastainer C. Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate. Acta Paediatr 2010;99:209-14. DOI 10.1111/j.1651-2227.2009.01547.x
9. Leikin JB, Mackendrick WP, Maloney GE, et al. Use of clonidine in the prevention and management of neonatal abstinence syndrome. Clin Toxicol (Phila) 2009;47:551-5. DOI 10.1080/15563650902980019
10. Agthe AG, Kim GR, Mathias KB, et al. Clonidine as adjunctive therapy to opioids for neonatal abstinence syndrome: a randomized controlled trial. Pediatrics 2009;123:e849-56. DOI 10.1542/peds.2008-0978